These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32956614)

  • 1. SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020.
    Akinbami LJ; Vuong N; Petersen LR; Sami S; Patel A; Lukacs SL; Mackey L; Grohskopf LA; Shehu A; Atas J
    Emerg Infect Dis; 2020 Dec; 26(12):2863-2871. PubMed ID: 32956614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
    Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P
    Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July-August 2020.
    Akinbami LJ; Chan PA; Vuong N; Sami S; Lewis D; Sheridan PE; Lukacs SL; Mackey L; Grohskopf LA; Patel A; Petersen LR
    Emerg Infect Dis; 2021 Mar; 27(3):823-834. PubMed ID: 33622481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.
    Poletti P; Tirani M; Cereda D; Guzzetta G; Trentini F; Marziano V; Toso C; Piatti A; Piccarreta R; Melegaro A; Andreassi A; Gramegna M; Ajelli M; Merler S
    JAMA Netw Open; 2021 Jul; 4(7):e2115699. PubMed ID: 34228126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
    Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
    JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System.
    Baker JM; Nelson KN; Overton E; Lopman BA; Lash TL; Photakis M; Jacob JT; Roback JD; Fridkin SK; Steinberg JP
    Ann Intern Med; 2021 May; 174(5):649-654. PubMed ID: 33513035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System.
    Fitzpatrick V; Rivelli A; Blair C; Copeland K; Richards J
    Public Health Rep; 2021 May; 136(3):361-367. PubMed ID: 33673779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
    Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study.
    Kahlert CR; Persi R; Güsewell S; Egger T; Leal-Neto OB; Sumer J; Flury D; Brucher A; Lemmenmeier E; Möller JC; Rieder P; Stocker R; Vuichard-Gysin D; Wiggli B; Albrich WC; Babouee Flury B; Besold U; Fehr J; Kuster SP; McGeer A; Risch L; Schlegel M; Friedl A; Vernazza P; Kohler P
    Clin Microbiol Infect; 2021 Sep; 27(9):1336-1344. PubMed ID: 34020033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.
    Nishida T; Iwahashi H; Yamauchi K; Kinoshita N; Okauchi Y; Suzuki N; Inada M; Abe K
    Medicine (Baltimore); 2021 Jun; 100(25):e26433. PubMed ID: 34160433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between personal protective equipment and SARS-CoV-2 infection risk in emergency department healthcare workers.
    Schmitz D; Vos M; Stolmeijer R; Lameijer H; Schönberger T; Gaakeer MI; de Groot B; Eikendal T; Wansink L; Ter Avest E
    Eur J Emerg Med; 2021 Jun; 28(3):202-209. PubMed ID: 33105329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022.
    Madinga J; Mbala-Kingebeni P; Nkuba-Ndaye A; Baketana-Kinzonzi L; Matungulu-Biyala E; Mutombo-Lupola P; Seghers CA; Smekens T; Ariën KK; Van Damme W; Kalk A; Peeters M; Ahuka-Mundeke S; Muyembe-Tamfum JJ; Vanlerberghe V
    J Health Popul Nutr; 2024 Jun; 43(1):74. PubMed ID: 38824595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.
    Brousseau N; Morin L; Ouakki M; Savard P; Quach C; Longtin Y; Cheng MP; Carignan A; Dufresne SF; Leduc JM; Lavallée C; Gauthier N; Bestman-Smith J; Arrieta MJ; Ishak M; Lévesque S; Martin P; De Serres G
    CMAJ; 2021 Dec; 193(49):E1868-E1877. PubMed ID: 34903591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence.
    Heyming TW; Sanger T; Tongol A; Schomberg J; Bacon K; Lara B
    West J Emerg Med; 2021 Apr; 22(3):565-571. PubMed ID: 34125028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: A multicenter seroprevalence study.
    Al-Maani A; Al Wahaibi A; Al-Sooti J; Al Abri B; Al Shukri I; AlRisi E; Al Abri L; AlDaghari K; Al Subhi M; AlMaqbali S; AlBurtamani S; AlAbri A; Al Salami A; Al-Beloushi I; Al-Zadjali N; Alqayoudhi A; Al-Kindi H; Al Shaqsi K; Al-Jardani A; Al-Abri S
    Int J Infect Dis; 2021 Jun; 107():257-263. PubMed ID: 33930541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study.
    Zhang S; Guo M; Wu F; Xiong N; Ma Y; Wang Z; Duan L; Chen L; Ouyang H; Jin Y
    Clin Microbiol Infect; 2020 Dec; 26(12):1670-1675. PubMed ID: 32911080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
    Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
    Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
    Ladoire S; Goussot V; Redersdorff E; Cueff A; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hanu R; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
    Eur J Cancer; 2021 May; 148():359-370. PubMed ID: 33780664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust.
    Grant JJ; Wilmore SMS; McCann NS; Donnelly O; Lai RWL; Kinsella MJ; Rochford HL; Patel T; Kelsey MC; Andrews JA
    Infect Control Hosp Epidemiol; 2021 Feb; 42(2):212-214. PubMed ID: 32746953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.